Description: Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.
Home Page: www.lifecore.com
LFCR Technical Analysis
3515 Lyman Boulevard
Chaska,
MN
55318
United States
Phone:
(952) 368-4300
Officers
| Name | Title |
|---|---|
| Mr. Paul Josephs | President, CEO & Director |
| Mr. James G. Hall | Advisor |
| Mr. Ryan D. Lake CPA | CFO & Secretary |
| Mr. Aaron Perlitsh | Director of Internal Audit & Chief Compliance Officer |
| Mr. Darren M. Hieber | Senior Vice President of Corporate Development & Partnerships |
| Ms. Brikkelle Thompson | Senior Vice President of Human Resources |
| Ms. Jackie Q. Klecker | Executive VP, Quality and Development Services & GM |
| Mr. Matt Augustson | Senior Vice President of Information Technology |
| Dr. Albert D. Bolles Ph.D. | President of Curation Foods, Inc. |
| Mr. Parker K. Javid | Vice President |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 8.673 |
|---|---|
| Trailing PE: | 58.3077 |
| Price-to-Book MRQ: | 15.3467 |
| Price-to-Sales TTM: | 2.2249 |
| IPO Date: | 1996-02-15 |
| Fiscal Year End: | May |
| Full Time Employees: | 524 |